Table 2.
Characteristics of patients with hepatocellular carcinoma1
| Characteristics | HIV+ (n = 10) | HIV- (n= 26) | P value |
| Age, yr | 42.1 ± 8.3 | 53.7 ± 10.6 | 0.004 |
| Male gender | 8 (80.0) | 18 (69.2) | 0.689 |
| Caucasian | 9 (90.0) | 24 (92.3) | > 0.999 |
| Diabetes or glucose intolerance | 2 (20.0) | 10 (41.7) | 0.432 |
| n = 9 | n = 22 | ||
| Alcohol | 7 (77.8) | 10 (45.5) | 0.132 |
| n = 10 | n = 26 | ||
| Hepatitis B | 1 (10.0) | 2 (7.7) | > 0.99 |
| Hepatitis C | 9 (90.0) | 24 (92.3) | > 0.99 |
| Child- Pugh | n = 8 | n = 25 | |
| A | 2 (25.0) | 11 (44.0) | 0.735 |
| B | 5 (62.5) | 11 (44.0) | |
| C | 1 (12.5) | 3 (12.0) | |
| n = 7 | n = 22 | ||
| MELD | 13.7 ± 5.1 | 10.9 ± 4.2 | 0.157 |
| n = 10 | n = 26 | ||
| Milan criteria2 | 3 (30.0) | 14 (53.8) | 0.157 |
| n = 10 | n = 24 | ||
| Alpha-fetoprotein, ng/mL | 276 (23-18750) | 20 (4-113) | 0.038 |
Data presented as average ± SD or n (%). 1All patients who developed hepatocellular carcinoma in this study had liver cirrhosis;
2
Patients with hepatocellular carcinoma satisfying the following criteria: single lesion < 5 cm or up to three lesions < 3 cm, without vascular tumor invasion and/or distant metastasis. HIV: Human immunodeficiency virus; MELD: Model for End-Stage Liver Disease.